Differential PAX5 levels promote malignant B cell infiltration, progression and drug resistance and predict a poor prognosis in MCL patients independent of CCND1

por Teo, Albert E., Chen, Zheng, Miranda, Roberto N., McDonnell, Timothy, Medeiros, L. Jeffrey, McCarty, Nami
Publicado 2015